Renal Oncocytoma — Multifaces Appearances
https://doi.org/10.37174/2587-7593-2026-9-2-37-44
Abstract
Introduction: The effectiveness of adjuvant radiation therapy used to consolidate the effect of chemotherapy in patients with
Purpose: To familiarize readers with the diverse imaging features of renal oncocytomas as seen on 4-phase CT/MRI contrast-enhanced study.
Materials and methods: This article is based on one of the largest clinical data, reflecting the wide variety of imaging features of renal oncocytoma in 61 patients who underwent preoperative 4-phase CT/MRI contrast-enhanced study of the abdomen, followed by surgical intervention (resection or nephrectomy) and morphological examination of the resected specimens.
Results: The significant diversity in the imaging patterns of oncocytomas depends on the heterogeneity of their morphological structure: marked differences in tumor cellularity, the volume of stroma, and the presence of hemorrhagic and/or cystic elements. This is why their imaging manifistations can overlap with the features of various types of renal cell carcinoma (clear cell, chromophobe cell, etc.), which significantly complicates the accurate preoperative diagnosis of oncocytoma using standard imaging methods (ultrasound, CT, MRI). The well-known and characteristic oncocytoma’s pattern “a spoke-wheel-like enhancement” we observed in only 4 of 61 patients.
Conclusion: Differential diagnosis between oncocytoma and renal cell carcinoma based on CT/MRI findings can be extremely difficult in most cases, but is still possible in a few patients.
About the Authors
N. Ts.‑D. DrobotRussian Federation
Natalia Ts.‑D. Drobot
23 Kashirskoye Highway, Moscow, 115522
Competing Interests:
The authors declare no conflict of interest
X. A. Romanova
Russian Federation
Xenia A. Romanova
23 Kashirskoye Highway, Moscow, 115522
Competing Interests:
The authors declare no conflict of interest
E. S. Topalov
Russian Federation
Еugeniy S. Topalov
23 Kashirskoye Highway, Moscow, 115522
Competing Interests:
The authors declare no conflict of interest
S. D. Beghanova
Russian Federation
Svetlana D. Beghanova
23 Kashirskoye Highway, Moscow, 115522
Competing Interests:
The authors declare no conflict of interest
A. V. Klimov
Russian Federation
Alexey V. Klimov
23 Kashirskoye Highway, Moscow, 115522
Competing Interests:
The authors declare no conflict of interest
B. M. Medvedeva
Russian Federation
Bela M. Medvedeva
23 Kashirskoye Highway, Moscow, 115522
Competing Interests:
The authors declare no conflict of interest
A. B. Lukianchenko
Russian Federation
Alexander B. Lukianchenko
23 Kashirskoye Highway, Moscow, 115522
Competing Interests:
The authors declare no conflict of interest
References
1. Clinical Oncology. Ed by B.P. Matveev, M. 2003, pp. 8-10 (In Russ.).
2. Ambos MA, Bosniak MA, Valensi QJ, et al. Angiographic patterns in renal oncocytomas. Radiology. 1978;129:615-22.
3. Perez-Ordonez B, Hamed G, Campbell S, et al. Renal Oncocytoma: A Clinicopathologic Study of 70 Cases. Am J Surg Pathol, 1997;21(8):871-83.
4. Ishigami K, Jones AR, Dahmoush L, et al. Imaging spectrum of renal oncocytomas: a pictorial review with pathologic correlation. Insights Imaging. 2015;6:53-64. https://doi.org/10.1007/s13244-014-0373-x
5. Stepanova YuA, Chekhoeva OA, Teplov AA, et al. Renal oncocytoma: differential diagnosis and treatment P.A. Herzen Journal of Oncology. 2019;8(2):113-9 https://doi.org/1017116/onkolog20198021113 (In Russ.).
6. Dechet CB, Bostwick DG, Blute ML, et al. Renal oncocytoma: Multifocality, bilateralism, metachronous tumor development and coexistent renal cell carcinoma J Urol 1999;162(1):40-42. https://doi.org/10.1097/00005392-199907000-00010.
7. Wobker SE, Williamson SR. Modern pathologic diagnosis of renal oncocytoma. J Kidney Cancer VHL. 2017;4 (4):1-12. https://doi.org/10.15586/jkcvhl201796.
8. Choudhary S, Rajesh A, Mayer NJ, et al. Renal oncocytoma: CT features cannot reliably distinguish oncocytoma from other renal neoplasms. Clin Radiol. 2009;64:517-22. https://doi.org/10.1016/j.crad.2008.12.011
9. Woo S, Cho JY, Kim SH, et al. Comparison of segmental enhancement inversion on biphasic MDCT between of small renal oncocytoma and chromophobe renal cell carcinomas. AJR, 2013;201:598-604. https://doi.org/10.2214/ajr.12.10372
10. Paño B, Macías N, Salvador R, et al. Usefulness of MDCT to Differentiate Between Renal Cell Carcinoma and Oncocytoma: Development of a Predictive Model. AJR. 2016;206:764-74. https://doi.org/10.2214/AJR.15.14815.
11. Sasaguri K, Takahashi N, Gomez-Cardona D. Small (< 4 cm) Renal Mass: Differentiation of Oncocytoma From Renal Cell Carcinoma on Biphasic Contrast-Enhanced CT. AJR 2015;205:999-1007. https://doi.org/10.2214/AJR.14.13966.
12. Galmiche Cl, Bernhard J-C, Yacoub M, et al. Is Multiparametric MRI Useful for Differentiating Oncocytomas From Chromophobe Renal Cell Carcinomas? AJR. 2017;208:343-50. https://doi.org/10.2214/AJR.16.16832.
13. Young JR, Coy H, Kim HJ, et al. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma. AJR. 2017;208:4,812-9. https://doi.org/10.2214/AJR.16.17152
14. Trpkov K, Yilmaz A, Uzer D, et al. Renal oncocytoma revisited: A clinicopathological study of 109 cases with emphasis on problematic diagnostic features. Histopathology. 2010;57(6):893-906. https://doi.org/10.1111/j1365-2559201003726x.
15. Nurenberg P, Sartony-D’Ambrosia, Szczepaniak L, et al. Magnetic resonance spectroscopy of renal and other retroperitoneal tumors. Curr Opin Urol 2002; Sept; 12(5):375-80. https://doi.org/10.1097/00042307-200209000-00002
16. Çevik G, Tozsin A, Erdoğan EG, et al. (January 24, 2023) Asymptomatic Giant Right Renal Oncocytoma: A Case Report. Cureus 15(1):e34129. https://doi.org/10.7759/cureus.34129.
17. Chao DH, Zisman A, Pantuck AJ, et al. Changing Concepts in the Management of Renal Oncocytoma. Urology. 2002,59:635-42. https://doi.org/10.1016/s0090-4295(01)01630-2
18. Hirota K, Ueno Y, Nogami M, et al. Role of 18F FDG PET in renal tumors: insights from WHO 2022 classification. Japanese Journal of Radiology (2025) 43:1078–1089. https://doi.org/10.1007/s11604-025-01761-1
19. Roussel E, Capitanio U, Kutikov A, et al. Novel Imaging Methods for Renal Mass Characterization: A Collaborative Review. European Urology, 2022;81(5):476-88, https://doi.org/10.1016/j.eururo.2022.01.040.
20. Liu F, Jia L, Zhou X, LYu. Radiomics to Differentiate Renal Oncocytoma from Clear Cell Renal Cell Carcinoma on Contrast-Enhanced CT: A Preliminary Study. Journal of Imaging Informatics in Medicine, 2026 https://doi.org/10.1007/s10278-026-01851-0
21. Choi JH, Kim JW, Lee JY, et al. Comparison of computed tomography findings between renal oncocytomas and chromophobe renal cell carcinomas. Korean J Urol. 2015;56:695-702. http://dx.doi.org/10.4111/kju.2015.56.10.695
22. Li X, Ma Q, Nie P, et al. A CT-based radiomics nomogram for differentiation of renal oncocytoma and chromophobe renal cell carcinoma with a central scar-matched study. Br J Radiol. 2021;95:20210534. https://doi.org/10.1259/bjr.20210534
23. Ahmad S, Manecksha R, Hayes BD, Grainger R. Case report of a symptomatic giant renal oncocytoma. Int J Surg Case Rep. 2011;2(6):83-85. ttps://doi.org/10.1016/j.ijscr.2010.11.006.
24. Ball DS, Friedman AC, Hartman DS, Radecki PD, Caroline DF. Scar sign of renal oncocytoma: Magnetic resonance imaging appearance and lack of specificity. Urol Radiol. 1986;8:46-8.
Review
For citations:
Drobot N.Ts., Romanova X.A., Topalov E.S., Beghanova S.D., Klimov A.V., Medvedeva B.M., Lukianchenko A.B. Renal Oncocytoma — Multifaces Appearances. Journal of oncology: diagnostic radiology and radiotherapy. 2026;9(2):37-44. (In Russ.) https://doi.org/10.37174/2587-7593-2026-9-2-37-44
JATS XML























